Hilltop Holdings Inc. Horizon Therapeutics Public LTD CO Transaction History

Hilltop Holdings Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $3,096 - $4,538	-39 Reduced 1.3%	2,950 $235,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $17,716 - $22,511	205 Added 7.36%	2,989 $314,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $37,748 - $45,925	383 Added 15.95%	2,784 $300,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $9,191 - $11,037	-100 Reduced 4.0%	2,401 $263,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $215,686 - $239,895	2,501 New	2,501 $234,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

Stay updated on Hilltop Holdings Inc. with notifications on news.